• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Vanda Pharmaceuticals Inc - Articles and news items

Phase III results for Vanda’s Hetlioz published in The Lancet

Industry news / 5 August 2015 / Victoria White

Pivotal trial results from Phase III studies of Vanda Pharmaceuticals’ Hetlioz® (tasimelteon) have been published in The Lancet…

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionWATCH NOW
+ +